# New Serum Biomarkers for Monitoring Early Diagnosis of Ovarian Cancer Recurrence

> **NCT05410028** · — · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **OTHER:** No intervention in clinical treatment

## Key facts

- **NCT ID:** NCT05410028
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-03
- **Primary completion:** 2024-03-03
- **Final completion:** 2026-03-03
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2022-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05410028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05410028, "New Serum Biomarkers for Monitoring Early Diagnosis of Ovarian Cancer Recurrence". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05410028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*